Safety and Efficacy of Adjunct Dexamethasone in Adults with Herpes Simplex Virus Encephalitis in The UK - Part 3

from Neurology Minute · host American Academy of Neurology

In part three of this series, Dr. Aaron Zelikovich discusses the clinical outcomes seen during and after the acute infection and how these findings can guide physicians in counseling their patients. Show citation: Solomon T, Hooper C, Easton A, et al. Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial. Lancet Neurol. 2026;25(2):136-146. doi:10.1016/S1474-4422(25)00454-5

Episode metadata supplied by the publisher feed · Published Jun 24, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Safety and Efficacy of Adjunct Dexamethasone in Adults with Herpes Simplex Virus Encephalitis in The UK - Part 3

0:00 2:38

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neurology Minute?

This episode is 2 minutes long.

When was this Neurology Minute episode published?

This episode was published on June 24, 2026.

Can I download this Neurology Minute episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!